BlackRock Group’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.22M Buy
50,550
+8,078
+19% +$225K ﹤0.01% 2036
2016
Q3
$1.18M Buy
42,472
+3,923
+10% +$104K ﹤0.01% 1943
2016
Q2
$941K Buy
38,549
+4,533
+13% +$129K ﹤0.01% 2000
2016
Q1
$1.14M Buy
34,016
+2,841
+9% +$89.4K ﹤0.01% 1873
2015
Q4
$932K Buy
31,175
+2,903
+10% +$97.8K ﹤0.01% 1944
2015
Q3
$890K Buy
28,272
+13,033
+86% +$636K ﹤0.01% 1952
2015
Q2
$738K Buy
15,239
+3,634
+31% +$153K ﹤0.01% 2108
2015
Q1
$503K Buy
11,605
+6,602
+132% +$237K ﹤0.01% 2201
2014
Q4
$131K Buy
5,003
+2,178
+77% +$47.8K ﹤0.01% 2613
2014
Q3
$50K Sell
2,825
-153
-5% -$3.12K ﹤0.01% 2686
2014
Q2
$72K Sell
2,978
-9,068
-75% -$184K ﹤0.01% 2649
2014
Q1
$303K Buy
12,046
+5,607
+87% +$155K ﹤0.01% 2371
2013
Q4
$146K Sell
6,439
-1,559
-19% -$31.5K ﹤0.01% 2457
2013
Q3
$181K Buy
+7,998
New +$185K ﹤0.01% 2508

Other funds holding PGEN

BlackRock Group's PGEN Position: Q4 2016 in Review

BlackRock Group increased its Precigen (PGEN) stake by 19% in Q4 2016, buying an estimated $225K and bringing the position to 50,550 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #2036.

BlackRock Group first reported a position in PGEN in Q3 2013 and has held it in 14 quarters since. 171 funds tracked by Wall St. Rank hold PGEN as of Q4 2016.

  • BlackRock Group held 50,550 shares of Precigen worth $1.22M as of Q4 2016.
  • BlackRock Group bought 8,078 Precigen shares in Q4 2016, an estimated $225K.
  • Precigen made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2036 holding.
  • BlackRock Group first reported a position in Precigen in Q3 2013 and has held it in 14 quarters since.
  • 171 funds tracked by Wall St. Rank held Precigen as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.